We first conducted a validation study to confirm the prognostic significance of KLK6 in a large group of ovarian tumour tissues using a new immunoassay of higher sensitivity and specificity than previously reported (Diamandis et al, 2000). This evidence concerns the gene KLK6 and ovarian neoplasm.